JAZZJazz Pharmaceuticals plc

JAZZ Stock Price, Valuation & Chart | Jazz Pharmaceuticals plc

Compare

$243.71-6.97 (-2.78%)

At close · 01 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology JAZZ intrinsic value JAZZ calculated fair value vs price

Overview Financials Dividends Ratios

JAZZ Historical price chart

JAZZ Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization15.31B

PE Ratio9.09

EPS26.82

Trading Volume1.07M

Today's High/Low252.56/243.06

Dividend Yield0.00

52 Week High/Low266.38/123.88

Shares Outstanding62.82M

JAZZ Financial Statement

JAZZ Analyst ratings

JAZZ Analysis & performance metrics

JAZZ Company profile

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States,…

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including…

JAZZ Management team

Name

Position

Renee D. GalaCOO

President & Chief Operating Officer

Robert Iannone M.D.

Executive Vice President, Chief Medical Officer and Global Head of Research & Development

Patricia Carr

Senior Vice President & Chief Accounting Officer

Philip L. JohnsonCFO

Executive Vice President & Chief Financial Officer

Samantha Pearce

Executive Vice President & Chief Commercial Officer

Jed Black M.D.

Senior Vice President of Sleep & CNS Medicine

Jeff MacdonaldCTO

Executive Director of Investor Relations

Neena M. Patil J.D.

Executive Vice President & Chief Legal Officer

Name

Position

Renee D. GalaCOO

President & Chief Operating Officer

Robert Iannone M.D.

Executive Vice President, Chief Medical Officer and Global Head of Research & Development

Patricia Carr

Senior Vice President & Chief Accounting Officer

Philip L. JohnsonCFO

Executive Vice President & Chief Financial Officer

Samantha Pearce

Executive Vice President & Chief Commercial Officer

Jed Black M.D.

Senior Vice President of Sleep & CNS Medicine

Jeff MacdonaldCTO

Executive Director of Investor Relations

Neena M. Patil J.D.

Executive Vice President & Chief Legal Officer

Management Team

Renee D. GalaCOO

President & Chief Operating Officer

Robert Iannone M.D.

Executive Vice President, Chief Medical Officer and Global Head of Research & Development

Patricia Carr

Senior Vice President & Chief Accounting Officer

Philip L. JohnsonCFO

Executive Vice President & Chief Financial Officer

Samantha Pearce

Executive Vice President & Chief Commercial Officer

Jed Black M.D.

Senior Vice President of Sleep & CNS Medicine

Jeff MacdonaldCTO

Executive Director of Investor Relations

Neena M. Patil J.D.

Executive Vice President & Chief Legal Officer

Management

Renee D. GalaCOO

President & Chief Operating Officer

Robert Iannone M.D.

Executive Vice President, Chief Medical Officer and Global Head of Research & Development

Patricia Carr

Senior Vice President & Chief Accounting Officer

Philip L. JohnsonCFO

Executive Vice President & Chief Financial Officer

Samantha Pearce

Executive Vice President & Chief Commercial Officer

Jed Black M.D.

Senior Vice President of Sleep & CNS Medicine

Jeff MacdonaldCTO

Executive Director of Investor Relations

Neena M. Patil J.D.

Executive Vice President & Chief Legal Officer

Total 8 executives

JAZZ Frequently asked questions

What is Jazz Pharmaceuticals plc (JAZZ) Stock Price?

Current stock price of Jazz Pharmaceuticals plc (JAZZ) stock is $243.71. The stock price is -2.78% lower in the session. The intraday range can be seen from this page. Volume of Jazz Pharmaceuticals plc (JAZZ) stock is 1.07M.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Jazz Pharmaceuticals plc (JAZZ) stock price going up or down today?

The stock price of Jazz Pharmaceuticals plc (JAZZ) can change with earnings, company news, and overall market sentiment. Jazz Pharmaceuticals plc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Jazz Pharmaceuticals plc stock expensive at its current price?

Whether Jazz Pharmaceuticals plc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for JAZZ on this page is 9.09. EPS on this page is 26.82. Compare those figures with peers and growth expectations before deciding if the current Jazz Pharmaceuticals plc price is justified.

How has the stock price of Jazz Pharmaceuticals plc (JAZZ) performed historically?

Historical performance for Jazz Pharmaceuticals plc (JAZZ) is shown on the price chart on this page. Review multi-period moves alongside volume to see how JAZZ reacted to past earnings and market events.

Should I buy Jazz Pharmaceuticals plc (JAZZ) stock, at this price?

Buying Jazz Pharmaceuticals plc (JAZZ) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.